Jorge E. Aranda-Cossio

Ignacio Chavez, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease.

Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease.

Journal: British journal of biomedical science

Published: March 06, 2026

Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention.

Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention.

Journal: BMC cardiovascular disorders

Published: October 16, 2025

Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.

Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.

Journal: Archivos de cardiologia de Mexico

Published: October 30, 2024

Barriers to adherence to secondary prevention therapy in patients with ischemic heart disease: a cross-sectional study of a Mexican reference center.

Barriers to adherence to secondary prevention therapy in patients with ischemic heart disease: a cross-sectional study of a Mexican reference center.

Journal: Archivos de cardiologia de Mexico

Published: September 03, 2024

Mexican Registry of Cardiomyopathies: baseline data, diagnostic strategies, and treatment approaches in Mexico.

Mexican Registry of Cardiomyopathies: baseline data, diagnostic strategies, and treatment approaches in Mexico.

Journal: Archivos de cardiologia de Mexico

Published: July 29, 2024

Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?

Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?

Journal: Cardiovascular drugs and therapy

Published: June 22, 2024

Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.

Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.

Journal: Archivos de cardiologia de Mexico

Published: April 22, 2024

Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation

Lifestyle modification and risk factor control in the prevention and treatment of atrial fibrillation

Journal: Archivos de cardiologia de Mexico

Published: February 21, 2024

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Journal: Archivos de cardiologia de Mexico

Published: January 01, 2024

Mexican positioning statement for the preparticipation screening and cardiovascular evaluation in athletes.

Mexican positioning statement for the preparticipation screening and cardiovascular evaluation in athletes.

Journal: Archivos de cardiologia de Mexico

Published: December 26, 2023

Toward a better understanding of cardiovascular risk in the transgender and gender-diverse community: a supplement to the Tijuana Declaration.

Toward a better understanding of cardiovascular risk in the transgender and gender-diverse community: a supplement to the Tijuana Declaration.

Journal: Archivos de cardiologia de Mexico

Published: November 22, 2023

Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action.

Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action.

Journal: Global heart

Published: July 11, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026